Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Deepak Balak, Margreet L.E. Romeijn, Tessa Kouwenhoven, Marijke Kamsteeg, Barbara Giovannone, Julia Drylewicz, Cynthia Catalina Aurora van Amerongen, Evelien M. Delemarre, Edward F. Knol, Femke van Wijk, Stefan Nierkens, Judith L. Thijs, Marie L.A. Schuttelaar, Marjolein S. de Bruin-Weller